The patients affected are those covered in Illinois, Texas, Oklahoma, New Mexico, and Montana, but not those with Medicare or Medicaid, the insurance giant says. Those five states are included in a ...

Patients with severe asthma initiated dupilumab and tezepelumab treatment more often than other biologics between 2022 and 2023, according to a poster presented here. “That seems to have held the test ...

Blue Cross Blue Shield mandates severe asthma patients self-administer drugs at home, unless their provider gets prior approval from the company.

Apogee's strong financial position, with $731.1 million in cash, funds operations through Q1 2028, de-risking its ambitious ...

The chronic obstructive pulmonary disease (COPD) market across the seven major markets (7MM: US, France, Germany, Italy, ...

A new study published in the journal of Respiratory Investigation showed that in actual clinical practice, starting a ...

Continuing our series, Dr Andrew Whittamore debunks some common myths about asthma – and explains some less well-known facts ...

Asthma Drugs Market Oral and injectable forms are expanding, especially for patients with severe asthma and those undergoing biologic treat ...

Biologics are made using parts of living organisms ... Nucala is prescribed for eosinophilic asthma in adults and children ages 6 years and older. Eosinophilic asthma is a type of severe asthma ...

The pharma giant recently announced a partnership with the Professional Pickleball Association (PPA) to help raise awareness for its eosinophilic asthma biologic Fasenra. The collaboration is a ...

There have been new developments in treatments for chronic spontaneous urticaria, with dupilumab, remibrutinib, and ...

All belong to a class of drugs known as biologics. The decision is expected to affect thousands of patients. It's estimated that between 5% and 10% of asthma patients have severe asthma ...